By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



11 rue de MOLSHEIM, 67082
Cedex      France
Phone: 011-33-3-88-27-91-21 Fax: 011-33-3-88-27-91-11



Gene Therapy


Human Genome Sciences, Inc.  Gene Therapy Partnerships

Company News
TRANSGENE (ENX:TNG) And SillaJen Announce Revised Agreement For Pexa-Vec Oncolytic Viral Therapy And Provide Update On Clinical Development 11/12/2015 12:23:04 PM
TRANSGENE (ENX:TNG) Announces Dosing Of First Patient With TG1050 For Treatment Of Chronic Hepatitis B Infection 11/4/2015 10:24:16 AM
TRANSGENE (ENX:TNG) Reports Third Quarter 2015 Financial Results 10/21/2015 10:17:52 AM
TRANSGENE (ENX:TNG) To Present At Ladenburg Thalmann 2015 Healthcare Conference In New York 9/23/2015 10:37:11 AM
TRANSGENE (ENX:TNG) Reports Financial Results For First Six Months Of 2015 9/11/2015 9:56:11 AM
TRANSGENE (ENX:TNG) Announces Final Overall Survival Data From Phase IIb TIME Trial With TG4010 Immunotherapy In Non-Small Cell Lung Cancer 9/8/2015 1:34:33 PM
TRANSGENE (ENX:TNG) Gives Pink Slips to 120 as Part of Restructuring Plan 6/29/2015 10:25:23 AM
ASCO15: TRANSGENE (ENX:TNG) Announces Positive New Results Presented At ASCO From Phase 2b TIME Trial With TG4010 Immunotherapy In Non-Small Cell Lung Cancer 6/1/2015 11:22:10 AM
TRANSGENE (ENX:TNG) Announces Participation At Upcoming Investor Events 5/18/2015 11:50:56 AM
TRANSGENE (ENX:TNG) Presents New Data With TG1050, An Immunotherapy Being Developed To Treat Chronic Hepatitis B, At The International Liver Congress 2015 4/23/2015 11:25:17 AM